Respiratory Health Association funds ground-breaking lung disease research locally at major institutions. Areas of focus have included asthma, chronic obstructive pulmonary disease (COPD), lung cancer, idiopathic pulmonary fibrosis (IPF), and more. These grants are designed to aid local scientists/investigators with generating the preliminary data necessary to compete for future federal funding.
Request for Applications (RFA)
The Requests for Applications (RFAs) seek innovative studies into the causes, mechanisms, and treatments of a specific lung disease, including pilot and feasibility studies for disease investigation and development and testing of new methodologies and models. Basic, clinical/translational and social/behavioral studies will be considered, with patient-oriented research being particularly valued.
The disease area(s) of focus change from year to year and award amounts are based on available resources. Project budgets are for one year in duration (July to June). This year, we request applications for:
- Idiopathic pulmonary fibrosis (IPF) – $25,000 award
- Lung Cancer – $75,000 award
Research Budget Sheet Templates are available in Excel.
Request for Applications Announced
December 9, 2022
Full Applications Due
March 10, 2023 by 5 PM Central Time
Anticipated Research Funding Awards Announced
On or about June 1, 2023
Award Project Period
July 1, 2023 to June 30, 2024
For more information about grant funding opportunities, contact Erica Salem, Sr. Director Strategy, Programs and Policy at email@example.com or 312-628-0235.